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The Pharmacy Gaze: Bodies in Pharmacy Practice 
 
Abstract 
 
The body is a central feature of pharmacy practice. Despite this and the increased 
sociological focus on bodies in health and social care practice, the nature of the body and the work 
undertaken upon it in pharmacy have not been explored. Drawing on semi-structured interviews with 
hospital and community pharmacists, this paper explores the ways in which bodies are constructed 
and managed in these two practice contexts. It is argued that pharmacists see patient bodies in 
particular ways given their expertise in medicines, which is conceptualised here as the ‘pharmacy 
gaze’. The notion of ‘complexity’, as a way of constructing the body, and the generation of 
‘algorithmic bodies’, as a way of managing this complexity, are shown to be central to the pharmacy 
gaze in both hospital and community contexts. In hospitals, complexity was located within a singular 
body which is increasingly rationalised to reduce costs and toxicity. In community practice, 
complexity arose from the multiplicity of bodies which pharmacists interact with in their multi-
faceted role as retailers, dispensers and public health practitioners. The paper concludes by reflecting 
on the ways in which current UK health policy may broaden the body work that English pharmacists 
undertake.  
Abstract word count: 196 
Total word count: 7,945 
Introduction 
The body is subject to much contemporary sociological attention, so much so that ‘many 
bodies… now roam the sociological landscape’ (Williams 2003: 3). Body work, that is to say the body 
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as the object of labour, has been a particularly pervasive analytical framework within medical 
sociology. Scholars have been interested in the production of the patient body in, amongst others, 
care work (Twigg 2000), complementary and alternative medicine (Gale 2011), intensive care 
(Carmel 2012) and sexual therapy (Cacchioni and Wolkowitz 2011). Despite this increased focus on 
the body in medical and healthcare practices, the body in pharmacy has been relatively neglected. 
For example, in their introduction to a special issue of this journal on body work in health and social 
care, Twigg et al. (2011: 171) argue that body work is a central component of many medical 
occupations such as ‘doctors, nurses, dentists, hygienists, paramedics and physiotherapists’ but 
overlook the centrality of the body to the work of pharmacists.  
The body is, however, fundamental to pharmacy practice as the entity to which medicines 
are administered and within which medicines’ pharmacological action occurs. The fields of 
pharmacokinetics (what effects the body has on drugs) and pharmacodynamics (what effects drugs 
have on the body) are, for example, central to pharmacists’ training and everyday decision-making. 
Moreover, community pharmacists in England have become increasingly involved in clinical and 
public health activities, such as providing glucose and blood pressure testing, supporting weight 
management and promoting healthy lifestyles (see Methodology for an outline of the English 
pharmacy system), which has broadened the ways in which pharmacists in this setting engage with 
the body. This paper is concerned with the construction of the body in English hospital and 
community pharmacy practice and the ways in which changes in the organisation of pharmacy 
practice alter pharmacists’ modes of engagement with bodies. It is argued that pharmacists cultivate 
a particular way of looking at or ‘seeing’ patient bodies, which is referred to here as the ‘pharmacy 
gaze’.     
It is argued that the pharmacy gaze, and the body which it constructs, is highly related to the 
particular context in which pharmacy practice is performed. In particular, hospital and community 
pharmacy produce different sorts of bodies as a result of the divergent structures of practice, 
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illnesses, medicines and technologies found in these settings (Bhakta 2010). The notion of bodily 
complexity is shown to be common to both practice settings, although the root of this complexity 
differs between bodies in hospital and community contexts. The use of testing devices to produce 
what is called here ‘algorithmic bodies’ is also common across both settings.  
The paper’s focus on pharmacists’ ways of seeing, or gazing at, the body sits with the work 
of Jewson (1976) and Pickstone (2000) in examining the constitution of the body by practitioners. 
The notion of ‘gazing’ in medical practice does of course evoke Foucault’s (1975) ‘clinical gaze’, 
which highlighted limits to ‘orthodox’ medicalisation critiques and argued for the wholly socially 
constituted nature of the body and disease (see Lupton 1997). Unlike Foucault’s clinical gaze, 
however, the pharmacy gaze is shown here to be largely unconcerned with the process of diagnosis 
which reflects pharmacists’ primary occupational focus on medicinal products. This not to say that 
pharmacists do not perform diagnostic work. Rather, particularly in the community setting, 
pharmacists are often involved in determining the potential causes of ill-defined symptoms and 
advising on the most appropriate treatments. Such diagnostic work, however, tends to centre on 
minor acute conditions requiring immediate, rather than long-term, treatment and is rarely formally 
recorded (for example in patient medical records) in the way that physician-centric diagnosis is.  
Moreover, the extent to which the pharmacy gaze can be understood as a tool of medical 
power and domination, as is suggested by Foucault’s clinical gaze, is also less straightforward. While 
Foucault draws attention principally to the discursive repertoires that provide the power and 
authority of the clinical gaze, here the pharmacy gaze focuses our attention on pharmacists’ role in 
medicines’ use, the rationing thereby of healthcare resources, encouraging concordance in patient 
medicine taking and encouraging patients to become lay managers of their own health. 
In developing this analysis, this paper contributes to the sociology of pharmacy, which has 
previously neglected analyses of the body and makes a novel contribution to the extant literature on 
bodies in professional practice, which has previously excluded pharmacy. The notion of algorithmic 
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bodies, moreover, represents a novel way of understanding the management of the body that may 
provide a useful framework for analysing body work in other medical and healthcare practice 
contexts.  
 
Pharmacy and the Body  
 
Although pharmacists in England play an important role in patients’ experience and 
management of health and illness, their everyday work is not as widely theorised within sociology as 
other healthcare practices. In particular, there has been a limited focus on the body in different 
pharmacy practice settings. This paper argues that pharmacists’ primary focus on medicines 
necessitates a symbolic engagement with the body, as the entity to which medicines are being 
administered. Given the financial implications of administering inappropriate medicines, it is shown 
that the body is increasingly standardised through testing devices and numerical outputs, which are 
used in medicines decision-making. Moreover, it is argued that the expansion of the role of 
community pharmacists into more clinical and public health activities, such as providing testing 
services and healthy living support, has incorporated new work tasks centred on engagement with 
the physical patient body.  This paper suggests that pharmacists in both hospital and community 
settings cultivate a particular way of seeing patient bodies given their expertise in medicines. 
Crucially, the nature of bodies produced through the pharmacy gaze is highly contingent on the 
context in which pharmacy practice is performed. As such, the divergent organisation of pharmacy in 
hospitals and in the community is shown to be key to the bodies that are thereby produced.  
 Body work is an increasingly pervasive analytical framework in sociology (Gimlin 2007, 
McDowell 2009, Wolkowitz 2006). Shilling (2011) argues that this interest in bodies can be seen in 
the works of Marx, Weber, Durkheim and Mauss (1973) and warns against an ‘amnesia’ regarding 
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the classical roots of the concept.  In the context of contemporary health and social care practices, 
body work is defined by Twigg et al. (2011: 173) as ‘work that focuses directly on the bodies of 
others, who thereby become the object of the worker’s labour’. Body work is, then, most commonly 
characterised by hands-on, intimate labour with physical bodies. This sort of work is often 
understood as ‘dirty’ work  and is, therefore, highly gendered, classed and racialised and mostly 
carried out by lower class, ethnic minority women (Neysmith and Aronson 1997, Twigg 2000, Twigg 
et al. 2011).  Kerr (2013), however, suggests that too narrow a definition of body work risks 
overlooking types of labour that may include absent bodies or those rendered visible through 
technology (see Måseide, 2011). She suggests that in the case of assisted conception, practitioners 
work with imagined bodies in determining ‘who gets treatment and how it is delivered’ (Kerr, 2013: 
476). These imagined, absent bodies are, nonetheless, a key part of everyday work and play a 
significant role in organising care. Given this, she suggests that the notion of body work be 
broadened to include work concerned with, but often remote from, patient bodies.  
Taking the cue from Kerr (2013), body work is taken here in its broader sense, as involving 
labour which is concerned with the body but does not necessitate hands-on activities. As such, it is 
shown that much of pharmacists’ work involving bodies is symbolic rather than physical, although 
the changes to the role of community pharmacists are shown to necessitate new forms of physical 
contact with patient bodies. In employing the notion of body work to the context of pharmacy this 
paper exemplifies the broad application of the framework to work activities involving bodies which 
are implicitly, if not physically, present.  
In addition, the paper speaks to Twigg et al.’s (2011) call for more comparative analysis of 
body work. It also contributes to the growing, although still comparatively limited, sociology of 
pharmacy. This literature has historically focused on pharmacists’ precarious professional identity 
and status, with community pharmacists’ dual, and possibly conflicting, role as retailers and health 
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care practitioners being a particularly pervasive theme (Birenbaum 1982, Denzin and Mettlin 1968, 
Edmunds and Calnan 2001, Harding and Taylor 1997).  
Whilst such a focus on professional status is undoubtedly important for sociological analyses 
of pharmacy, Dingwall and Wilson (1995: 126) suggested that it is ‘far more profitable to focus 
attention on finding out just what kind of occupation pharmacy is than on sitting in judgement on its 
status claims’. Rather than focusing on the extent to which pharmacists have control over drugs, 
Dingwall and Wilson (1995: 119) examined the ways in which pharmacists inscribe inert chemical 
compounds with social and cultural meanings to become a ‘human product with a symbolic and 
cultural dimension’. For Barber (2005) pharmacists’ pharmacological expertise and the symbolic 
constitution of medicines that it enables characterise the distinctiveness of pharmacy practice 
through what he terms the ‘pharmaceutical gaze’. He conceptualised the pharmaceutical gaze as the 
‘ability to see into the properties of medicines, and predict their effects’ which ‘no other profession 
has’.  
Whilst this focus on what pharmacists do and the symbolic and constructive role that they 
play has engaged with pharmacists’ symbolic construction of medicines, much less attention has 
been paid to the construction of the patient body to which medicines are administered. This paper 
suggests that the process of imbuing inert chemicals with social meanings is one which necessarily 
involves the construction of medicines and patient bodies. Pharmacy’s focus on medicinal ‘stuff’, 
particularly around risk and potential adverse effects, necessarily brings the patient body into being 
as it is within the patient body that medicinal ‘stuff’ is acting and through the patient body that 
effects (both clinically beneficial and adverse) are expressed.  
Given this, this paper demonstrates that an analysis of what pharmacists do, in the vein of 
Dingwall and Wilson (1995) and others, needs to be attentive to the construction of the patient body 
within the performance of pharmacy practice. This is also echoed by Ryan et al. (2005: 51) who 
suggest that pharmacy’s concern with medicines compliance, concordance and adherence makes it 
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‘fertile ground’ for an exploration of the body within it. By examining the particularities of bodies 
and body work in English pharmacy practice, this paper make a novel contribution to the literatures 
on body work and the sociology of pharmacy. 
Methodology 
 
Context: Pharmacy in the UK 
 
 At the time of the 2008 pharmacy workforce census (Seston and Hassell 2009), there were 
48,749 registered pharmacists in the UK (England, Scotland and Wales). Over 90% of these were 
concentrated in community (71%) and hospital (21.4%) practice settings with the remainder working 
in primary care (7.2%), academia (2.8%) and industry (4.1%)1. This paper is concerned with 
pharmacists working in hospital and community settings in England.  
Since the 1980s, the structures of both community and hospital pharmacy practice in 
England have altered considerably with practice moving, both physically and symbolically, out of the 
dispensary and into more clinical work on the shop floor and at the patient bedside (Anderson 
2001). 
 In the hospital setting, this increased clinical work is characterised by in-patient ‘counselling’ 
about medicines at the bedside, what has previously been known as ‘ward pharmacy’ (Stone and 
Curtis 2002). In the community setting, it has involved the expansion of the Community Pharmacy 
Contractual Framework (the ‘Pharmacy Contract’) to include more clinical services such as 
prescribed medicines management, common ailments services and the promotion of healthy 
lifestyles (Harding and Taylor 1997). This has broadened the scope of community pharmacy work to 
incorporate increased work with physical patient bodies. The community Pharmacy Contract 
currently incorporates three types of services; Essential, Advanced and Enhanced. ‘Essential services’ 
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are provided by all pharmacies and include dispensing, repeat dispensing and medications disposal. 
‘Advanced services’, such as Medicines Use Reviews (MURs) and New Medicines Services (NMS), can 
be provided by pharmacists once practitioners have been accredited to carry out such work. 
‘Enhanced services’ are commissioned locally and include activities such as needle exchange 
programmes and Chlamydia screening. Community pharmacies are remunerated a nationally 
standardised amount (set by the UK Pharmaceutical Services Negotiating Committee) for each 
service that they carry out (i.e. each prescription they dispense or MUR they complete). 
 These changes to the everyday work of pharmacists have generated a sociological interest in 
pharmacy practice, particularly around the effect of pharmacists’ extended role on practice 
boundaries (Mesler 1991) and professional identities (Harding and Taylor 1997). Much less 
attention, however, has been paid to the ways in which this clinical work has broadened 
pharmacists’ engagement with patient bodies.  
 
The Study 
 
 The findings presented here are drawn from a larger study of pharmacogenetics (PGx), or 
stratified medicine, in hospital and community pharmacy practice in England (Jamie, 2012). The 
purpose of this study was to examine the ways in which PGx may impact on the everyday work of 
pharmacists and their relationships with patient bodies. It has been argued elsewhere that PGx may 
have significant effects on the everyday work of pharmacists in hospital and community settings 
(Clemerson et al. 2006, Jamie 2011, Ryan et al. 2004). In particular, it is likely that PGx will generate a 
more molecular approach to patient bodies where toxicity risks are increasingly linked to, and 
controlled through, genetic markers.  
 Given this, the study aimed to examine the ways in which PGx in pharmacy was perceived by 
practitioners involved in PGx research and pharmacy practice. The study was concerned with three 
broad areas; the structure of contemporary English pharmacy practice; new technologies in hospital 
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and community practice; and the particularities of PGx in English pharmacy. The body was found to 
be a particularly salient theme cutting across all three of these areas. Although the topic of the body 
was not explicitly explored in the interviews, throughout the data analysis it was clear that the body 
is a central part of contemporary pharmacy practice. Moreover, it was also evident that the 
pharmacists’ engagement with the body is not fixed and shifts along with the work of pharmacists 
themselves. The sub-themes of complexity and algorithms, as a framework for managing this 
complexity, were common to both hospital and community practitioners although enacted 
divergently across these contexts.  
 
Data Collection 
 
The data for this paper are drawn from semi-structured interviews with 20 English 
pharmacists, 10 of whom are hospital practitioners and 10 of whom are community pharmacists. 
These 20 respondents form part of a larger sample of 38 professionals recruited from a diversity of 
practice backgrounds for the larger study of the potential effects of PGx on pharmacy. The 
perspectives of this subset of participants are presented here as those most engaged with 
pharmacists’ relationships with patient bodies.  
Of the 10 hospital pharmacists, 2 were directors of pharmacy departments, 2 worked in 
specialist Oncology hospitals and 1 was currently a health economist who had previously worked as 
a hospital pharmacist. Of the 10 community practitioners, 9 worked in medium or larger multiple 
pharmacies and 1 was an independent pharmacy owner.  
Hospital pharmacists were recruited using purposive and snowball sampling techniques. Six 
potential participants were identified for inclusion early on given the nature of their role or their 
involvement in PGx research or practice. Five of these potential participants were eventually 
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interviewed.  One of the remaining hospital pharmacists was recruited through a community 
pharmacist and the other 4 were recruiting using one of the directors of pharmacy as a gatekeeper.   
In the case of community pharmacists, 2 potential participants were identified because of 
their accredited special interest in Warfarin therapy given Warfarin’s potential centrality to PGx 
research and practice (Wadelius and Pirmohamed 2006).   One of these participants was eventually 
interviewed. Establishing, and maintaining, contact with community pharmacists was difficult as 
they rarely have personal email addresses online; tend only to respond to medical or general queries 
(for example, questions about opening times or testing services) through their practice email 
address; and receive large volumes of postal correspondence which means that non-essential mail is 
usually discarded. Moreover, approaching pharmacists in their branches, which was done on two 
occasions, did not yield participants. Professional bodies such as Local Practice Forums offer a 
potential way of accessing samples of community pharmacists but these were unresponsive to 
correspondence in this case.  Therefore, the most effective method for recruitment proved to be 
through informal contact with gatekeepers and snowball techniques, through which method 8 of the 
community pharmacy participants were recruited. The remaining 1 community pharmacist was 
recruited through invitation letters sent to every pharmacy within one city in northern England. The 
study was presented to participants as focusing on the potential implications of PGx for pharmacists 
although the recruitment literature emphasised that pre-existing knowledge of genetics in general, 
and PGx more specifically, was not necessary. Instead, it was made clear to pharmacists that they 
would be asked to reflect on their experiences of pharmacy practice and its future. It may be that 
the relatively technoscientific topic of study was a factor in the low response rate for community 
pharmacists. However, those that were interviewed commented on the relevance of the project and 
of increasingly innovative areas of practice given pharmacy’s perceived precariousness.   
Interviews with hospital pharmacists were carried out in cafes during breaks or in offices 
during designated meeting times in the case of participants with access to office space.  Interviews 
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with community pharmacists were carried out outside of working hours and premises, in cafes. Each 
interview lasted between 40 and 90 minutes, was recorded and transcribed verbatim by a 
professional transcriber. Although the notion of ‘saturation’ is ambiguous, interviews were carried 
out until no new ideas were emerging.  
 
Data Analysis 
 
 The data were analysed thematically in two stages using an inductive approach and a 
combination of manual coding and Atlas.Ti software. Since the data were transcribed by a 
professional transcriber, a month was dedicated entirely to the process of repeatedly reading the 
data to achieve the familiarity with it which may have been lost through sub-contracting of 
transcribing work. Following this stage, the initial phase of data analysis identified the data 
pertaining to three broad categories of interest for the project; the structure of contemporary 
English pharmacy practice; new technologies in pharmacy practice; and the particularities of PGx in 
pharmacy practice. This analysis took an inductive approach which allowed for the identification of 
themes pertaining to pharmacy in particular settings as well as themes common to both hospital and 
community pharmacy.    
 A number of themes which intersected these broad categories of interest were identified. 
The body was the most salient theme to emerge where multiple practitioners made reference to 
patient bodies with varying degrees of explicitness. Within this, the sub-themes of complexity and 
the generation of bodily algorithms were identified as being common to both hospital and 
community practice, although enacted differently in these settings. The data suggested, then, that 
pharmacists cultivate a particular way of seeing and narrating the patient body based on their 
medicines expertise, the pharmacy gaze.  
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Findings 
 
Context of Practice 
The everyday work of pharmacy practice in hospital and community contexts is highly 
divergent in terms of the working structures, illnesses, medicines and technologies found in these 
different settings (Bhakta 2010). The context in which pharmacy work is performed was shown to be 
a key factor in the ways in which bodies are constructed through the pharmacy gaze in particular 
pharmacy settings. Despite these divergences, the notion of complexity and the generation of bodily 
algorithms through testing devices were common to pharmacists’ relationships with patient bodies 
across both settings.  
 
Bodily Complexity 
 
 The notion of bodies as complex entities was prevalent in both hospital and community 
pharmacy practice. In the hospital context, in-patient bodies were represented as singular but 
complex entities in need of closer expert management than those in community settings. Such 
complexity was often located within a poly-pharmacy regimen and the risk of drug-drug interactions 
and adverse effects that these carry. Hospital Pharmacist 10, who was currently a health economist 
but had previously practised as a hospital pharmacist, demonstrated this poly-pharmacy complexity 
in the case of transplant in-patients; 
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“People who were post-bone marrow transplantation and they’d be on quite extensive drug 
regimens… I’d go through their medications with them and help them about how to organise their 25 
medicines a day” (HP 10) 
    
As well as drug regimen, this bodily complexity was also linked with its particular illness and 
the field of medical expertise within which the patient body was being treated and managed.  A 
notable example which was repeatedly drawn on in the interviews was the field of Oncology where 
the cancer patient body was understood as being particularly complex given the nature of cancer as 
an illness and the increased toxicity of Oncology medications, as an Oncology pharmacist suggested: 
  
“The body is very complex so how does it handle the drugs? Effects from the tumour, effects from the 
patient’s body, the rate of liver metabolism” (HP 3- Oncology)  
 
 In Oncology, the prescribing and dispensing of medicines was represented as being a 
manifold process owing to the complexity of the cancer patient body and the effects that this 
complexity may have on the medicines’ effectiveness. In this way, the body and its complexities are 
brought into being by, and within, medication decisions.  
The organisation of everyday work in hospital settings was thought to provide a structure 
within which this bodily complexity could be managed. The collaborative practice structure in English 
hospitals produces something of a collective practitioner gaze where diverse expertise acts 
collaboratively to construct and manage bodily complexity (also see May 1992). In other words, in 
hospital contexts where patients encounter multiple practitioners, the body becomes subject to 
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multiple practitioner gazes all of which construct it in particular ways given their field of expertise 
but all of which focus on the patient body as a single site for body work.  
These practitioner gazes work together in order to understand the patient body and its 
complexities and develop the most effective therapy regime for it.  As such, the pharmacy gaze and 
the way in which the patient body is constructed through it, was located as one of many practitioner 
gazes which operate in the hospital setting to manage bodily complexity and medicines toxicity, as 
Hospital Pharmacist 3 suggested in the case of Oncology practice;  
 
“On the wards you’ll have the junior doctors, the nurses and pharmacy. So pharmacy is there to 
advise the both junior doctors and the nurses about medications and all sorts of things” (HP3, 
Oncology)  
  
Given this model of collaboration in hospital settings, pharmacists engage with and 
negotiate practitioner gazes other than that of their own profession in their everyday work activities. 
This collaborative approach to constructing and managing the patient body is supported by hospital 
work structures in which practitioners are co-located within the physical boundaries of the hospital 
building and where policy, generally, allows all hospital practitioners to have access to patient 
medical records. A director of a hospital pharmacy department, for example, demonstrated the ways 
in which a multiplicity of practitioner gazes were collated in the patient medical record;  
 
 “It’s not just pharmacy but OTs [occupational therapists] and physios and all sorts of people who 
have access…all write in the patient’s notes” (HP 6- Director of Pharmacy)  
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This quote echoes Berg and Bowker’s (1997) suggestion that patient medical records are 
fundamental  to the everyday production of the patient body as it is within the patient medical 
records that multiple practitioner expertise are collated and an account of the patient body is 
produced. In this way, the patient medical record can be understood as a device through which 
bodily complexity is constructed and the pharmacy gaze enacted. 
Patient medical records were something that community pharmacists also drew attention 
to. In the UK, community pharmacists have limited access to patient medical records, which 
Community Pharmacist 1 suggested limits pharmacists’ access to an emergent singular body as in 
the hospital context;  
 
“You cannot access a patient’s data or medical information, at least nothing to do with their health” 
(CP 1)  
 
Given this restriction, the complexities of a singular patient body both in terms of diagnostic 
processes and prescription decisions are not as easily constructed by, and knowable to, community 
pharmacists as hospital practitioners. Nonetheless, bodily complexity still characterises community 
pharmacy practice in England, although it is rooted in the multiplicity of bodies, rather than the 
complexity of singular bodies.  
Whilst most community pharmacy respondents talked of what might be understood as 
patient bodies, that is to say bodies with particular biological dysfunctions or illnesses in need of 
medication, many of the responses also highlighted the presence of what might be called a public 
health body in community pharmacy. This body is constructed less in terms of its illnesses and 
medications and more through the discourses of public health campaigns and the measurers of 
‘good health’ that they present. These sorts of public health bodies are, then, rarely what might be 
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considered patient bodies in that it is health maintenance, rather than illness, which motivates visits 
to the pharmacy. Many of the respondents talked about the co-presence of patient and public 
health bodies creating a grey area in how to understand and refer to those using the pharmacy, as 
Community Pharmacist 10 demonstrated;  
 
“If people are in for advice or testing, they’re not really patients…because there’s possibly nothing 
wrong with them. But they’re not customers either because they’re not actually buying things” (CP 
10).   
 
A third body, what might be understood as a consumer body, can also be seen in this quote. 
This body is positioned as distinct from the patient and public health bodies in using the pharmacy to 
purchase products rather than because they are ill or seeking public health advice. This suggests that 
pharmacists in community settings negotiate bodily complexity of a different kind than their hospital 
counterparts. Whereas complexity in the hospital setting is located in what is most certainly a 
singular patient body, in the community setting complexity is rooted in the ambiguity and volatility 
of multiple body identities, motivations and clinical destinations. It is challenging for pharmacists to 
combine these multiple bodies into a singular body found in the hospital setting given that these 
bodies are rarely brought together through interventions based on a convergent diagnosis.  
This complex nature of the body also impacts on the nature of the community pharmacy 
space where the identity of pharmacy premises becomes ambiguous owing to the multiplicity of 
bodies within it. In this way, the pharmacy space was represented by Community Pharmacist 10 as 
taking on divergent meanings according to the needs of the particular bodies which entered it where 
“a pharmacy can be different things for different people depending on what they want that 
particular day” (CP 10). As such, whilst the retail nature of the pharmacy space may be of secondary 
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importance for individuals seeking public health advice, the pharmacy as a therapeutic space may 
also be undermined by the potential for there to be “nothing wrong” (CP 10).   
The expansion of the community pharmacy gaze to incorporate public health activities and 
bodies was understood by community pharmacists to have reorganised pharmacist/patient 
interactions and created new modes through which pharmacists physically interact with bodies. It 
was also thought to have necessitated the integration of a divergent set of skills into the 
performance of everyday community pharmacy work, as Community Pharmacist 2 showed; 
 
“We’ve never actually touched patients before…. Pharmacists are generally not used to touching 
patients. Communication as well is not something that pharmacists in the past have needed much of 
because they were always hidden away in the dispensaries, whereas now pharmacists have got to 
get used to talking to people, taking their blood pressure, pricking their fingers, etcetera”  (CP 2)  
 
Within this quote it can be seen that the increased public health role of pharmacy has 
broadened the way in which community pharmacists engage with physical bodies. This role has, 
then, engaged practitioners with new practices of body work in which the body has increasingly 
become the object of a new form of pharmacy labour. This organisation of community pharmacy 
work around public health body work in contemporary public health concerns was also understood 
as being a key characteristic of future English community pharmacy practice and the pharmacy gaze. 
A number of respondents suggested that concerns about the future role of community pharmacy, 
particularly around increased de-regulation and online pharmacy, could be addressed through the 
diversification of everyday work into more public health-centred activities;  
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“I think community pharmacy can only increase its public health profile really. Get more involved in 
screening for things like sexual health…get more involved in some of the issues we’ve got around 
obesity, weight management problems” (CP 2)  
 
 This anticipated reconfiguration of the pharmacy gaze fits with Taylor’s (2005: 292) view of 
the future of community pharmacists as ‘the people’s doctors’ and current UK public health policy 
which positions community pharmacists as central practitioners in public health services (see 
Department of Health, 2008). This potential future of the pharmacy gaze raises questions about 
possible shifts in the nature of body work in pharmacy. For example, at present, the public health 
work of pharmacists is, generally, not what might be understood as ‘dirty’ but a move towards a 
focus on sexual health may bring more ‘matter out of place’ into the English community pharmacy.  
 Managing the complexity of bodies in both hospital and community practice was 
represented as a central feature of the performance of pharmacy work. To do this, bodies are 
rationalised and standardised to sit with medicines decisions-making processes. The most pervasive 
way in which this is carried out is through the use of testing devices and their numerical outputs to 
create what are called here ‘algorithmic bodies’.  
Constructing Algorithmic Bodies 
 
Creating algorithmic bodies involves the reduction of the complexities of the patient body 
into a series of numerical values and algorithms through the use of testing devices. These algorithms 
standardise bodies and are mobilised in decision making to manage complexity in both hospital and 
community pharmacy contexts, although the nature of them varies between these two settings.  
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In the hospital context, algorithms provide a set of numerical values and criteria through 
which prescribing and dispensing decisions can be made. These algorithms provide a way through 
which the patient body, and its complexities, can be more easily measured and linked with the most 
effective drug therapy regime in order to reduce the potential for drug toxicity. Moreover, the use of 
algorithms in hospital contexts supports the movement of patient bodies towards a common goal: 
their biological recovery, or at least stability, and removal from the hospital setting.  Hospital 
Pharmacist 9 (an Oncology pharmacist) and 4 demonstrated the mobilisation of algorithmic 
approaches in the everyday work of prescription checking;   
 
“In order to screen a prescription for chemotherapy you would need to check certain aspects of the 
patient” (HP 9- Oncology) 
 
“You’re going to have to check that those criteria have been met before the drug’s actually released 
or dispensed” (HP 4).  
 
Hospital Pharmacist 4 went on to provide examples of what these “criteria” of patient 
bodies might be in the case of chemotherapy;  
 
“You don’t have to be neutropenic, your blood counts need to be in an appropriate range and your 
renal function has to be adequate before certain medicine will be released” (HP 4)   
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 This construction of bodies in algorithmic terms was highly linked with testing activities and 
technologies where the outcomes of diverse, clinically relevant tests, such as those mentioned 
above, form the measurements of complexity and, therefore, the basis of prescribing and dispensing 
decisions. For pharmacists, the algorithmic construction of complex patient bodies was primarily 
located within the performance of prescription checking as part of dispensing work to ensure an 
appropriate ‘fit’ between the patient body and the medicine being dispensed for it. Further 
‘upstream’ of pharmacists’ and their checking work, these numerical test results also constitute the 
body in algorithmic terms for prescribers. Pharmacists are often also involved in these prescribing 
decisions in hospitals.  
As well as enabling the management of toxicity for the benefit of patients’ experiences of 
their medicines, this standardisation of hospital patient bodies through algorithms is also rooted in 
financial considerations. In hospital contexts where comparatively high-cost medications are 
prescribed, prescription and dispensing decisions are mediated by their financial implications and 
the construction of a bodily algorithm becomes a way of ensuring that money is not wasted through 
the dispensing of inappropriate medicines. A director of a hospital pharmacy department highlighted 
this in respect to new Oncology medicines;  
 
“They are expensive and therefore we’re a lot clearer than we used to be about protocols for 
treatment and criteria for treatment” (HP 6- Director of Pharmacy)  
 
This articulated a clear link between the cost of new, innovative medicines and an 
increasingly rigorous pre-prescription body screening process in the hospital setting. Here, the 
practice of using algorithms was placed within a changing context where evidence and resources 
need to take priority:  as Hospital Pharmacist 6 went on to say;  
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“It used to be that new drugs would come out and consultants would try them and see what 
happened whereas now it’s far more focused on the evidence base and making sure that patients are 
selected appropriately” (HP6- Director of Pharmacy) 
 
These quotes also represent shifting approaches to hospital prescribing practices away from 
a “willy-nilly” (HP 9- Oncology), one-size-fits-all approach to one in which medicines are increasingly 
targeted at particular patient bodies based on the results of pre-prescription tests. A comment from 
Community Pharmacist 6 suggested that this targeted prescribing and dispensing model was 
particularly linked with hospital practice and the patient bodies within it given the costs and 
complexities of medicines in this setting, compared with those in the community which are less 
expensive and problematic vis-à-vis adverse effects;  
 
“If we look at things like Codeine, you could just try it and if it don’t work you try something else 
because it’s so cheap to try” (CP 6)   
 
For Hospital Pharmacist 10, this increased rationalisation of prescribing practices created a 
tension between saving money and supplying potentially useful medicines for patients, as she 
described in the case of transplant patients and new HIV medicines in the 1990s;  
 
 “They [hospital Trust] were really focused on trying to save money. And it was at the time where we 
did a lot of bone marrow transplants and had a lot of patients who were HIV positive…There were a 
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lot of people who had been infected through contaminated blood products…There were these new 
treatment options coming on-board all the time yet we were told to save money all the time” (HP 10)  
 
 In the community context, such rationalisation of prescribing and dispensing decisions 
through the use of algorithms is not as pervasive given the comparatively low cost and low toxicity 
of medications. Community pharmacists’ lack of access to patient medical records also means that 
pharmacists in this setting do not have enough patient data to standardise the patient body the 
same way as in the hospital setting. Moreover, whilst singular hospital patient bodies are, generally, 
moving towards a common goal of recovery and removal from the hospital space, the multiplicity of 
bodies in community settings means no such common goal exists. In other words, multiplicitous 
bodies in community pharmacy may be moving towards a diversity of goals, not just ‘recovery’. 
Nonetheless, testing technologies and the algorithms they produce form an integral part of the 
management of, in particular, public health bodies in community pharmacy practice. Testing in the 
community pharmacy context, then, reduces the body into a series of characteristics which can be 
related to public health measures, such as high cholesterol or blood pressure. Unlike in hospital 
contexts these bodily algorithms involve the construction of the body as a series of characteristics 
which enable individuals to become lay managers of their own health rather than for the purpose of 
prescribing and dispensing decisions and, ultimately, the removal of the body from the setting. As 
such, the algorithms produced in community pharmacy are not what we might understand as 
therapy algorithms as in the hospital setting.  
 Algorithmic bodies in community pharmacy are, instead, produced to identify potential 
health risks. Testing devices were presented in the data as central artefacts in the production of 
these algorithmic bodies. Community Pharmacist 3 highlighted the use of such testing devices to 
calculate potential cardiovascular disease risks;  
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 “I was offering cholesterol testing as well as CVD [Cardiovascular Disease] calculations. So that was 
cholesterol, blood pressure test, heart monitoring and in that respect calculating patients’ CVD risk” 
(CP 3) 
 
 In this way, the community pharmacy gaze is focused on the body as a site of potential 
health risk brought about by its own characteristics (for example, having high cholesterol or blood 
pressure) which are measured, through algorithms, against the normative levels set by public health 
campaigns. These algorithmic bodies, or parts thereof, then become the objects around which other 
body work activities, such as weight management programmes, become organised.  
 
Discussion and Conclusion 
This paper has examined the ways in which English hospital and community pharmacists 
interact with patient bodies both symbolically and physically in the everyday performance of work. It 
has been shown that changes to the organisation of pharmacy practice have altered pharmacists’ 
modes of engagement with patient bodies. This is particularly the case in the community pharmacy 
setting where the increased clinical and public health role of pharmacists has necessitated new 
forms of body work.   
The findings have indicated that pharmacists cultivate a particular way of constructing and 
managing the patient body given their pharmacological expertise, conceptualised here as the 
pharmacy gaze. This notion of the pharmacy gaze extends Barber’s (2005) notion of the 
pharmaceutical gaze and captures the related notions of bodies, complexity, algorithms and risk, all 
of which are enacted upon, and through, bodies in everyday pharmacy practice.  
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It has been argued here that despite the divergence between the everyday work of 
pharmacists in hospital and community settings, the body is central to the performance of English 
pharmacy practice across these two contexts. In particular, it has been shown that the notion of 
bodies as complex entities, and the mobilisation of algorithmic methods for managing this 
complexity, are common to both hospital and community pharmacy practice. In hospitals, 
complexity has been shown to centre on a singular patient body where complexity arises from the 
interactions between this singular body and relatively toxic hospital medications. In contrast, the 
complexity of the body in community pharmacy has been shown to be rooted in the multiplicity of 
bodies which English pharmacists interact with in their multi-faceted, and sometimes unclear, role. 
In both hospital and community contexts, the production of algorithmic bodies through the use of 
testing devices was represented by the respondents as a way in which bodies are standardised and 
bodily complexity managed to achieve beneficial therapeutic and public health outcomes.  
In developing this novel framework, this paper makes a number of contributions to the 
extant literature in the fields of the sociology of pharmacy practice and body work. In employing the 
notion of body work to examine pharmacists’ engagement with patient bodies, this paper echoes 
Kerr’s (2013) argument that the concept can be broadened to incorporate forms of work which are 
concerned with, but also remote from, the physical body itself. As such, it is shown here that 
symbolic processes of constructing bodies may also usefully be understood as forms of body work.   
The notion of algorithmic bodies also makes a novel contribution to this field, particularly around 
decision making. This framework may also prove useful in understanding the ways in which bodies 
are constructed and managed in other healthcare practices. In addition, this algorithmic bodies 
framework may also provide an analytical tool for analysing patient’s understandings of their 
medicines regimen and the extent to which these regimen are ‘working’. Whilst patient 
understandings of medicines has been explored to some extent elsewhere (Cohen et al. 2005, 
Webster et al. 2009), the algorithmic bodies framework may offer a novel perspective.  
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There are a number of limitations to this present work. Firstly, the data presented here is 
based on interviews rather than observational methods. This is because this data is part of a larger 
study  on PGx in pharmacy, for which interviews were the most appropriate methods for eliciting 
reflections about past, present and future practice. It would, however, be beneficial for future work 
to investigate body work in pharmacy through the use of observations and contextual inquiry 
methods. Secondly, the sample presented here is not representative of all UK pharmacists. In the 
case of hospital practitioners in particular, obtaining a representative sample of all hospital 
pharmacists would be extremely challenging given the diversity of specialisms that hospital 
pharmacists practice in. The strong focus on Oncology pharmacists in this paper is indicative of the 
focus of the wider project on PGx, in which Oncology is a particularly notable field. Future work in 
this area would benefit from a more representative sample of respondents taken from a more 
diverse range of clinical specialisms. Thirdly, it was particularly challenging to recruit community 
pharmacists for participation. Given the time constraints in this particular project, snowball sampling 
proved to be the most effective method. Securing co-operation from professional bodies such as the 
Royal Pharmaceutical Society and the National Pharmacy Association may be useful, as would 
placing advertisements in pharmacy publications. However, there may also be scope for future 
researchers to use social media tools such as the pharmacy-forum.co.uk website, Twitter or 
YouTube.  
Currently UK health policy also offers a number of directions in which this present work 
could be advanced. Firstly, the current move towards medicines ‘optimisation’, in which patients and 
their wider cultural practices are increasingly involved in prescription decision making (Cutler 2011), 
may provide a useful lens through which to re-engage in research around pharmacists’ symbolic 
construction of medicines and bodies in everyday practice. In this vein, the framework of the 
pharmacy gaze proposed here may provide a useful analytical tool to understand the ways in which 
medicines and patient bodies are dually constructed in pharmacy/patient encounters to arrive at an 
optimised therapy regime. Moreover, bodily algorithms may also prove to be a useful way through 
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which the complexities of bodies, medicines and patients’ cultural lives can be captured within an 
optimisation framework.  Secondly, the formation of the policy body Public Health England in April 
2013 places pharmacists at the centre of public health campaigns and practices following the 
implementation of Healthy Living Pharmacies in some areas. This may potentially have wide ranging 
impacts on pharmacy practice such as shifting professional identities and new forms of body work 
characterising everyday practice.  
Endnotes 
1 This total is more than 100% as pharmacists may be employed in two practice settings at the same time.  
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